The California Assembly Health Committee has published an analysis of AB463, the Pharmaceutical Cost Transparency Act of 2015. The bill will be marked up by the committee on Tuesday (April 21). The analysis was written by Dharia McGrew. It recommends three amendments to the bill, and provides a discussion of the benefits of the required disclosures, with context, and describes the support and opposition. The staff report is attached, and below is a list of 33 groups supporting and 22 opposing the bill. The supporters are a diverse collection of consumer groups, unions, health care providers and insurance companies, and business and employer groups. The 22 groups opposing the bill are mostly drug companies, and interestingly, do not include some of the better known drug companies, such as BMS, Gilead, Merck or J&J, although these companies are represented by BIO and PhRMA, which both oppose the bill.
REGISTERED SUPPORT / OPPOSITION:
Support
- AIDS Healthcare Foundation
- America’s Health Insurance Plans
- Anthem Blue Cross
- Association of California Life and Health Insurance Companies
- Blue Shield of California
- California Association of Health Plans
- California Hepatitis Alliance
- California Labor Federation
- California Nurses Association
- California PACE Association
- California School Employees Association
- California Teachers Association
- Consumers Union
- Fresno Chamber of Commerce
- Greater West Covina Business Association
- Health Access
- Health Net
- Industry Manufacturers Council
- Kaiser Permanente
- Laborers International Union of North America Local 777 and 792
- Los Angeles Area Chamber of Commerce
- Molina Healthcare
- National Multiple Sclerosis Society
- Ontario Chamber of Commerce
- Richmond Chamber of Commerce
- San Gabriel Valley Economic Partnership
- San Gabriel Valley Regional Chamber of Commerce
- SEIU California
- Small Business Majority
- State Building and Construction Trades Council, AFL-CIO
- Torrance Area Chamber of Commerce
- Torrance Area Chamber of Commerce Governmental Affairs Policy Group
- Valley Industry and Commerce Association
Opposition
- AbbVie
- Allergan
- Amgen
- Astellas Pharma
- BayBio
- Biocom
- Biogen
- Bayer
- BioMarin Pharmaceutical
- Biotechnology Industry Organization
- Boehringer-Ingelheim
- California Healthcare Institute
- California Manufacturers & Technology Association
- Eisai
- Genzyme
- Orange County Business Council
- Otsuka Pharmaceutical Development & Commercialization, Inc
- Pfizer
- Pharmaceuticals Research and Manufacturers of America
- Sanofi
- Sunovion
- Takeda Pharmaceutical Company